Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,21,1.89 [1.56-2.3],8.6050586117058e-11,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,21,1.24 [1.16-1.32],1.33723834848695e-10,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,21,1.38 [1.21-1.58],1.97096036179223e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,21,0.93 [0.89-0.96],6.3063588187187e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSB,Cathepsin B,Inverse variance weighted,21,0.91 [0.87-0.96],0.000189894118895698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,21,0.92 [0.89-0.96],0.00025816371783192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,21,0.94 [0.91-0.97],0.000316207745723231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCN3,CCN family member 3,Inverse variance weighted,21,0.93 [0.89-0.97],0.000471027769230181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,21,0.9 [0.84-0.95],0.000477350515454896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,21,1.07 [1.03-1.12],0.000708587020147094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLTP,Phospholipid transfer protein,Inverse variance weighted,21,0.92 [0.87-0.96],0.000799951471510551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,21,0.88 [0.82-0.95],0.000895992484515513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,21,0.95 [0.93-0.98],0.001386845141323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,21,0.95 [0.92-0.98],0.00180145063496584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPON2,Spondin-2,Inverse variance weighted,21,0.93 [0.88-0.97],0.00296091833163423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASET2,Ribonuclease T2,Inverse variance weighted,21,0.95 [0.91-0.98],0.00403328557273161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.05 [1.01-1.09],0.00635652354701874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EFNA1,Ephrin-A1,Inverse variance weighted,21,0.94 [0.89-0.98],0.00714074920221426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LMNB2,Lamin-B2,Inverse variance weighted,21,0.94 [0.91-0.99],0.00821528895104356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NECTIN2,Nectin-2,Inverse variance weighted,21,0.91 [0.84-0.98],0.00863359742688734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,APOC1,Apolipoprotein C-I,Inverse variance weighted,21,0.86 [0.77-0.96],0.00993662675428328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,21,0.93 [0.87-0.98],0.0116195068634556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,21,0.94 [0.89-0.99],0.0132629189681008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,21,1.04 [1.01-1.08],0.0137022373152023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PSAP,Prosaposin,Inverse variance weighted,21,0.94 [0.9-0.99],0.0152351225140552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,21,1.44 [1.07-1.92],0.0154780356853097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,21,0.95 [0.91-0.99],0.0157478733667338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM3C,Protein FAM3C,Inverse variance weighted,21,0.95 [0.91-0.99],0.0171422157532982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,21,0.93 [0.88-0.99],0.0171607791223624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD83,CD83 antigen,Inverse variance weighted,21,0.94 [0.9-0.99],0.0172855758156183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,21,0.95 [0.91-0.99],0.0178700749013509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.95 [0.91-0.99],0.0184068147808411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,21,0.96 [0.93-0.99],0.0185267685696387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,21,0.95 [0.9-0.99],0.0197996361771285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,21,0.88 [0.78-0.98],0.0217554139163426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,21,0.94 [0.9-0.99],0.0220186634220525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,21,0.95 [0.92-0.99],0.0239395458315558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,21,0.95 [0.91-0.99],0.028435582742201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,OGN,Mimecan,Inverse variance weighted,21,0.97 [0.93-1],0.0295553244677047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.96 [0.92-1],0.0309049499447192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPPB,Natriuretic peptides B,Inverse variance weighted,21,1.03 [1-1.07],0.0341033882227516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,21,0.97 [0.94-1],0.0365980463238706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,APOM,Apolipoprotein M,Inverse variance weighted,21,1.06 [1-1.12],0.0392991023069216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FURIN,Furin,Inverse variance weighted,21,0.95 [0.9-1],0.0394869448748731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EDN1,Endothelin-1,Inverse variance weighted,21,0.96 [0.92-1],0.0395484654213953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,21,0.94 [0.88-1],0.0424335009121246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,21,1.09 [1-1.19],0.0445991017955981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,21,0.94 [0.89-1],0.0447028460444328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,21,0.97 [0.94-1],0.0456714495680576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,21,0.96 [0.92-1],0.0515686941838337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,21,0.97 [0.94-1],0.0596478730401363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,21,0.89 [0.79-1.01],0.0629789961393121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL21,C-C motif chemokine 21,Inverse variance weighted,21,1.04 [1-1.09],0.0657618643090177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MMP7,Matrilysin,Inverse variance weighted,21,1.04 [1-1.09],0.0709986054752815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CDH2,Cadherin-2,Inverse variance weighted,21,0.94 [0.88-1.01],0.0713314278648146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,21,0.96 [0.93-1],0.0722694374063264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.97 [0.93-1],0.0736978771359813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANGPT2,Angiopoietin-2,Inverse variance weighted,21,0.92 [0.84-1.01],0.0760102445218578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,21,0.97 [0.94-1],0.0919514596711612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SHISA5,Protein shisa-5,Inverse variance weighted,21,0.97 [0.93-1.01],0.0927402183505229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,21,0.94 [0.87-1.01],0.093423962939808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CST3,Cystatin-C,Inverse variance weighted,21,0.97 [0.93-1.01],0.095108014648614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,21,1.03 [0.99-1.08],0.0951127693331153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,21,0.97 [0.94-1.01],0.095249578627913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,21,1.04 [0.99-1.1],0.0985067859060008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,21,0.97 [0.94-1.01],0.0991623157856643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPO,Erythropoietin,Inverse variance weighted,21,1.03 [0.99-1.06],0.100585230011589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AGRN,Agrin,Inverse variance weighted,21,0.97 [0.92-1.01],0.101969702354022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,21,0.97 [0.93-1.01],0.10251828223932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL22,C-C motif chemokine 22,Inverse variance weighted,21,1.04 [0.99-1.09],0.105604122191046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EFNA4,Ephrin-A4,Inverse variance weighted,21,0.96 [0.91-1.01],0.107092687731303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,21,0.97 [0.94-1.01],0.110915708904648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,21,1.06 [0.99-1.15],0.112261154652834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,21,0.97 [0.93-1.01],0.114138358380027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,21,0.96 [0.92-1.01],0.114492195465996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE6,Ribonuclease K6,Inverse variance weighted,21,0.97 [0.94-1.01],0.114954854243244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PROC,Vitamin K-dependent protein C,Inverse variance weighted,21,1.06 [0.99-1.14],0.116099283111627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COLEC12,Collectin-12,Inverse variance weighted,21,0.97 [0.93-1.01],0.123164772814804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,21,0.97 [0.93-1.01],0.129492899177927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,21,0.97 [0.94-1.01],0.133387075703412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,21,0.97 [0.94-1.01],0.144991119166873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM3B,Protein FAM3B,Inverse variance weighted,21,0.94 [0.87-1.02],0.149352153658356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAYN,Layilin,Inverse variance weighted,21,0.96 [0.91-1.02],0.157443325774251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,21,1.05 [0.98-1.12],0.162888815233351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CFD,Complement factor D,Inverse variance weighted,21,0.98 [0.95-1.01],0.165912845533042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,21,0.97 [0.93-1.01],0.170155419040168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MFGE8,Lactadherin,Inverse variance weighted,21,1.09 [0.96-1.23],0.186103787362277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,21,1.03 [0.98-1.08],0.191433351750947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,21,0.96 [0.91-1.02],0.193812349680473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,21,0.98 [0.95-1.01],0.195638183841904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,21,0.97 [0.93-1.01],0.198204324365201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,21,0.96 [0.91-1.02],0.204063403071525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,21,0.97 [0.92-1.02],0.204861419222088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,21,1.05 [0.98-1.12],0.206005181227919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,21,1.02 [0.99-1.05],0.206462304647811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,INHBC,Inhibin beta C chain,Inverse variance weighted,21,0.97 [0.94-1.01],0.2085077776028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BCHE,Cholinesterase,Inverse variance weighted,21,1.03 [0.98-1.08],0.2105879417116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HGF,Hepatocyte growth factor,Inverse variance weighted,21,0.98 [0.95-1.01],0.212728615454992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EGFR,Epidermal growth factor receptor,Inverse variance weighted,21,0.98 [0.94-1.01],0.21398340556772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LEP,Leptin,Inverse variance weighted,21,0.98 [0.94-1.01],0.216913083664909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,21,0.98 [0.94-1.01],0.21897484944424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GUCA2A,Guanylin,Inverse variance weighted,21,1.04 [0.98-1.1],0.225835118777899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,21,1.03 [0.98-1.08],0.226150533867282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,21,1.06 [0.96-1.17],0.236620168078896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,F7,Coagulation factor VII,Inverse variance weighted,21,0.97 [0.91-1.02],0.241850272894985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,21,0.97 [0.93-1.02],0.242582190106119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,21,0.97 [0.93-1.02],0.243309113821563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,21,1.05 [0.97-1.14],0.244786750444602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,21,0.98 [0.95-1.01],0.248976120928193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,21,0.98 [0.95-1.01],0.248992647039234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,21,1.04 [0.97-1.1],0.252857282055669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,21,0.98 [0.95-1.01],0.252900922805133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPL,N-acetylneuraminate lyase,Inverse variance weighted,21,0.97 [0.91-1.03],0.25427573824689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VWC2,Brorin,Inverse variance weighted,21,0.97 [0.93-1.02],0.254418310917905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,21,0.98 [0.95-1.01],0.25491371088548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AOC3,Membrane primary amine oxidase,Inverse variance weighted,21,0.98 [0.94-1.02],0.261670735407264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,21,0.98 [0.95-1.01],0.267245025675997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,21,0.86 [0.67-1.12],0.267582317945896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MVK,Mevalonate kinase,Inverse variance weighted,21,1.03 [0.98-1.08],0.269311657442539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,21,0.98 [0.95-1.01],0.271116901035802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,21,0.98 [0.95-1.02],0.27320990608594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,21,0.98 [0.95-1.02],0.274674730466803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,21,0.98 [0.94-1.02],0.286882753662344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD59,CD59 glycoprotein,Inverse variance weighted,21,0.98 [0.96-1.01],0.293153529522196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GAST,Gastrin,Inverse variance weighted,21,1.02 [0.99-1.05],0.294670334784006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,21,1.03 [0.98-1.08],0.302336223022345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,21,1.04 [0.97-1.12],0.303186501013362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,21,0.98 [0.94-1.02],0.306262531077816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CFI,Complement factor I,Inverse variance weighted,21,1.02 [0.98-1.06],0.307521824172479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,21,1.02 [0.98-1.06],0.307709405935527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPON1,Spondin-1,Inverse variance weighted,21,0.97 [0.93-1.02],0.310758664659627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD302,CD302 antigen,Inverse variance weighted,21,0.97 [0.9-1.03],0.316153083679776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GLA,Alpha-galactosidase A,Inverse variance weighted,21,1.02 [0.98-1.07],0.327161612871442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,21,0.98 [0.95-1.02],0.330954047811933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NEFL,Neurofilament light polypeptide,Inverse variance weighted,21,1.02 [0.98-1.05],0.341716584301294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,21,0.99 [0.96-1.01],0.342011441577769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL17,C-C motif chemokine 17,Inverse variance weighted,21,1.03 [0.97-1.08],0.346108243217937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,21,0.98 [0.95-1.02],0.359933040464091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRSS2,Trypsin-2,Inverse variance weighted,21,0.97 [0.92-1.03],0.377901885615489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,21,0.98 [0.94-1.02],0.382951575119408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,21,0.95 [0.85-1.07],0.391540628601106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,21,1.07 [0.91-1.26],0.393467617225301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,21,0.98 [0.95-1.02],0.397837866245823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TCN2,Transcobalamin-2,Inverse variance weighted,21,0.98 [0.93-1.03],0.398637024063734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GRN,Progranulin,Inverse variance weighted,21,1.23 [0.76-1.99],0.401269390093655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,21,0.97 [0.91-1.04],0.401963832009395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCN1,CCN family member 1,Inverse variance weighted,21,1.05 [0.93-1.19],0.403176381867571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,21,0.98 [0.93-1.03],0.40360159361083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF2,Trefoil factor 2,Inverse variance weighted,21,1.02 [0.98-1.06],0.404770031597131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,21,0.99 [0.96-1.02],0.406053412222586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,21,0.98 [0.94-1.03],0.413786955077933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCLY,Selenocysteine lyase,Inverse variance weighted,21,1.02 [0.98-1.06],0.4161506371798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,21,1.02 [0.97-1.06],0.424261514852544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NFASC,Neurofascin,Inverse variance weighted,21,0.97 [0.9-1.05],0.430052759637997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,21,0.98 [0.92-1.04],0.431511732947786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,21,0.98 [0.93-1.03],0.434248679676486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,21,0.98 [0.93-1.03],0.43530830672095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,21,0.99 [0.96-1.02],0.437195274696343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AGRP,Agouti-related protein,Inverse variance weighted,21,1.06 [0.91-1.23],0.437481740050416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REN,Renin,Inverse variance weighted,21,1.02 [0.97-1.06],0.440230489421216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CNTN3,Contactin-3,Inverse variance weighted,21,1.02 [0.97-1.07],0.452398556749072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HSPB6,Heat shock protein beta-6,Inverse variance weighted,21,0.98 [0.94-1.03],0.452859259577729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NUCB2,Nucleobindin-2,Inverse variance weighted,21,1.02 [0.97-1.08],0.453749583764963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,21,1.04 [0.94-1.14],0.453932215075583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,21,0.98 [0.94-1.03],0.459372474088213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF3,Trefoil factor 3,Inverse variance weighted,21,0.98 [0.94-1.03],0.465052692430582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,21,1.03 [0.96-1.1],0.466845617879407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL15,C-C motif chemokine 15,Inverse variance weighted,21,0.96 [0.87-1.07],0.473759905929012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,21,1.03 [0.94-1.13],0.477028387465954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FUOM,Fucose mutarotase,Inverse variance weighted,21,1.02 [0.96-1.08],0.478811960819399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLG,Plasminogen,Inverse variance weighted,21,1.02 [0.97-1.06],0.480860500209927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.99 [0.95-1.03],0.489831373711251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,21,1.03 [0.95-1.12],0.495464698208581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ITGA11,Integrin alpha-11,Inverse variance weighted,21,0.98 [0.92-1.04],0.495961740223966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,21,1.02 [0.96-1.09],0.496627379992724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSS,Cathepsin S,Inverse variance weighted,21,0.98 [0.92-1.04],0.500580221124512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,21,0.95 [0.82-1.1],0.508547863964277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HEG1,Protein HEG homolog 1,Inverse variance weighted,21,0.9 [0.67-1.22],0.50980273146189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,21,0.95 [0.82-1.11],0.519484951189514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MUC13,Mucin-13,Inverse variance weighted,21,0.94 [0.79-1.13],0.519586182903488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GDF15,Growth/differentiation factor 15,Inverse variance weighted,21,0.99 [0.96-1.02],0.522332654177417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,21,0.98 [0.93-1.04],0.523585340452303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPY,Pro-neuropeptide Y,Inverse variance weighted,21,1.04 [0.91-1.19],0.523627840770803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GOLM2,Protein GOLM2,Inverse variance weighted,21,1.07 [0.87-1.3],0.529950344201547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,21,0.98 [0.92-1.04],0.531016978219572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCG2,Secretogranin-2,Inverse variance weighted,21,0.98 [0.92-1.04],0.532714183333218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,21,1.06 [0.88-1.28],0.547162918621993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,21,1.06 [0.88-1.28],0.559055917891062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,21,0.99 [0.95-1.03],0.559863640062916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SERPIND1,Heparin cofactor 2,Inverse variance weighted,21,1.01 [0.97-1.07],0.570528107470599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PALM2,Paralemmin-2,Inverse variance weighted,21,0.99 [0.95-1.03],0.571718153632379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE4,Ribonuclease 4,Inverse variance weighted,21,0.99 [0.94-1.04],0.572565061041224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PTN,Pleiotrophin,Inverse variance weighted,21,0.98 [0.92-1.05],0.575472138038559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,21,0.98 [0.92-1.05],0.593910718165238,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AMBP,Protein AMBP,Inverse variance weighted,21,0.99 [0.96-1.02],0.601949489309178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,21,0.98 [0.93-1.04],0.603654089154543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,21,0.98 [0.92-1.05],0.610664269573129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.02 [0.95-1.09],0.61915564373488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,F9,Coagulation factor IX,Inverse variance weighted,21,0.99 [0.93-1.04],0.619231420010897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG1B,Lithostathine-1-beta,Inverse variance weighted,21,1.03 [0.92-1.15],0.626603325161853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MENT,Protein MENT,Inverse variance weighted,21,0.91 [0.62-1.34],0.627946081476963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANXA10,Annexin A10,Inverse variance weighted,21,1.01 [0.97-1.06],0.632652198122013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,21,0.99 [0.93-1.05],0.635597837382376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL23,C-C motif chemokine 23,Inverse variance weighted,21,1.02 [0.93-1.13],0.63852919746111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,APCS,Serum amyloid P-component,Inverse variance weighted,21,1.01 [0.96-1.07],0.641343070695914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,21,0.99 [0.97-1.02],0.642887619127313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,21,1.02 [0.94-1.11],0.643141986140739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,UPB1,Beta-ureidopropionase,Inverse variance weighted,21,1.01 [0.96-1.06],0.643353899839154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RBP5,Retinol-binding protein 5,Inverse variance weighted,21,1.01 [0.96-1.06],0.644622885841961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ELN,Elastin,Inverse variance weighted,21,1.02 [0.94-1.1],0.647135457814643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,21,1.01 [0.96-1.07],0.650135234446067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,21,1.01 [0.95-1.08],0.669150729671337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,21,0.98 [0.9-1.07],0.669730376623029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,21,1.01 [0.97-1.06],0.67327234064005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GCG,Pro-glucagon,Inverse variance weighted,21,1.02 [0.93-1.12],0.685384199361481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,21,0.98 [0.89-1.08],0.687344685958243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HYAL1,Hyaluronidase-1,Inverse variance weighted,21,1.01 [0.95-1.07],0.690846025557451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,21,1.01 [0.97-1.05],0.698378807911617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,21,1.02 [0.94-1.1],0.699335523477473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,XG,Glycoprotein Xg,Inverse variance weighted,21,1 [0.97-1.02],0.703869414279476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,21,0.99 [0.96-1.03],0.704467896513263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MDK,Midkine,Inverse variance weighted,21,1.01 [0.96-1.06],0.708097848229062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD276,CD276 antigen,Inverse variance weighted,21,1 [0.97-1.02],0.712766545455973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADM,Pro-adrenomedullin,Inverse variance weighted,21,1.01 [0.97-1.05],0.713427883801267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,21,0.99 [0.95-1.03],0.714924618996918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,21,0.99 [0.93-1.05],0.721558153937425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL27,C-C motif chemokine 27,Inverse variance weighted,21,1.02 [0.91-1.15],0.722471951919561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANG,Angiogenin,Inverse variance weighted,21,0.99 [0.95-1.04],0.723264773934195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHGA,Chromogranin-A,Inverse variance weighted,21,0.99 [0.95-1.04],0.7268975335809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSD,Cathepsin D,Inverse variance weighted,21,0.99 [0.94-1.05],0.746055743386974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.01 [0.93-1.11],0.74673659862236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PGA4,Pepsin A-4,Inverse variance weighted,21,0.99 [0.93-1.05],0.748138087195292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS9,Galectin-9,Inverse variance weighted,21,1.01 [0.96-1.05],0.755208440051347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,21,1 [0.97-1.02],0.770692628121478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS4,Galectin-4,Inverse variance weighted,21,0.94 [0.62-1.43],0.772394091334881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.01 [0.95-1.07],0.773262447208463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,21,1.01 [0.96-1.06],0.778871505645091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,21,0.98 [0.88-1.11],0.792998856180414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,21,0.99 [0.94-1.05],0.796350077255436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,21,1.01 [0.96-1.06],0.799502693333724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,21,0.99 [0.94-1.05],0.800248435043752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,OMD,Osteomodulin,Inverse variance weighted,21,1 [0.96-1.03],0.80573154075573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,21,0.99 [0.94-1.05],0.808536036043297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,21,1.01 [0.93-1.1],0.810320275324519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,UMOD,Uromodulin,Inverse variance weighted,21,1 [0.97-1.04],0.816731749515631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,21,0.99 [0.93-1.06],0.818607924822327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,C7,Complement component C7,Inverse variance weighted,21,1 [0.97-1.04],0.829803637392257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SOST,Sclerostin,Inverse variance weighted,21,1.01 [0.95-1.06],0.835969468439227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,21,1.01 [0.94-1.08],0.839700524302597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MME,Neprilysin,Inverse variance weighted,21,1 [0.96-1.05],0.842629379705864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,POF1B,Protein POF1B,Inverse variance weighted,21,1 [0.97-1.04],0.845271466938526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,21,1 [0.95-1.04],0.860128258028505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,21,1 [0.95-1.06],0.864376652111536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRSS8,Prostasin,Inverse variance weighted,21,1 [0.96-1.05],0.864992958514057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PGF,Placenta growth factor,Inverse variance weighted,21,1 [0.97-1.04],0.868565061882205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,21,1.01 [0.93-1.1],0.875589191577075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,21,1.01 [0.94-1.07],0.878052833750408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL16,C-C motif chemokine 16,Inverse variance weighted,21,1 [0.95-1.06],0.888767858907118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,21,1 [0.94-1.06],0.909846190186511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,21,1 [0.96-1.05],0.911978430399925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,21,1 [0.91-1.08],0.915264701080055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS3,Galectin-3,Inverse variance weighted,21,1 [0.95-1.05],0.922677041152974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DTNB,Dystrobrevin beta,Inverse variance weighted,21,1 [0.95-1.05],0.929207561898622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CPM,Carboxypeptidase M,Inverse variance weighted,21,1 [0.93-1.07],0.932641524006394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,21,1 [0.95-1.05],0.934425079540969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL7,C-C motif chemokine 7,Inverse variance weighted,21,1 [0.96-1.04],0.935788307888753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CSTB,Cystatin-B,Inverse variance weighted,21,1 [0.97-1.03],0.945432077704404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSO,Cathepsin O,Inverse variance weighted,21,1 [0.91-1.1],0.955426098205148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RTBDN,Retbindin,Inverse variance weighted,21,1 [0.94-1.07],0.95757388047322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,21,1 [0.91-1.09],0.964604474354978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,21,1 [0.96-1.04],0.967831632350216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,21,1 [0.94-1.06],0.970371049677135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PENK,Proenkephalin-A,Inverse variance weighted,21,1 [0.94-1.06],0.977620830656616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AREG,Amphiregulin,Inverse variance weighted,21,1 [0.93-1.07],0.979354010148215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,OCLN,Occludin,Inverse variance weighted,21,1 [0.96-1.04],0.993773412535409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF1,Trefoil factor 1,Inverse variance weighted,21,1 [0.96-1.04],0.996270152075736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,21,1 [0.96-1.04],0.996963186282475,trans
